Sectors
CLBT
Cellebrite DI Ltd.
12.00
2 x 8.64
2 x 15.24
bid
ask
+
0.01
0.08%
2 @ 04:15 PM
12.00 +0.00 (0.00%)
| Ytd | -33.44% | |
| 1y | -26.83% |
11.80
day range
12.13
9.58
52 week range
19.98
| Open | 11.80 | Prev Close | 11.99 | Low | 11.80 | High | 12.13 | Mkt Cap | 3.01B |
| Vol | 1.33M | Avg Vol | 2.80M | EPS | 0.23 | P/E | 52.17 | Forward P/E | 18.37 |
| Beta | 1.18 | Short Ratio | 2.58 | Inst. Own | 51.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 14.11 | 200-d Avg | 14.84 | 1yr Est | 15.36 |
| Income Statement | |||
| Total Revenue | 131.14M | ||
| Revenues (USD) | 131.14M | ||
| Cost of Revenue | 25.21M | ||
| Gross Profit | 105.93M | ||
| Operating Expenses | 98.98M | ||
| Research and Development Expense | 35.96M | ||
| Selling, General and Administrative Expense | 63.02M | ||
| Operating Income | 6.95M | ||
| Interest Expense | -4.24M | ||
| Income Tax Expense | 4.82M | ||
| Net Income | 6.37M | ||
| Net Income Common Stock | 6.37M | ||
| Net Income Common Stock (USD) | 6.37M | ||
| Consolidated Income | 6.37M | ||
| Earnings per Basic Share | 0.03 | ||
| Earnings per Basic Share (USD) | 0.03 | ||
| Earnings per Diluted Share | 0.02 | ||
| Earning Before Interest & Taxes (EBIT) | 6.95M | ||
| Earning Before Interest & Taxes (USD) | 6.95M | ||
| Weighted Average Shares | 247.62M | ||
| Weighted Average Shares Diluted | 252.79M | ||
| Balance Sheet | |||
| Cash and Equivalents | 141.25M | ||
| Cash and Equivalents (USD) | 141.25M | ||
| Investments | 404.47M | ||
| Investments Current | 301.28M | ||
| Investments Non-Current | 103.19M | ||
| Trade and Non-Trade Receivables | 110.78M | ||
| Current Assets | 589.68M | ||
| Property, Plant & Equipment Net | 40.97M | ||
| Total Assets | 994.31M | ||
| Debt Current | 5.74M | ||
| Total Debt | 23.23M | ||
| Current Liabilities | 364.21M | ||
| Debt Non-Current | 17.49M | ||
| Total Liabilities | 456.21M | ||
| Accumulated Retained Earnings (Deficit) | -69.23M | ||
| Accumulated Other Comprehensive Income | 1.60M | ||
| Shareholders Equity | 538.10M | ||
| Shareholders Equity (USD) | 538.10M | ||
| Assets Non-Current | 404.63M | ||
| Total Debt (USD) | 23.23M | ||
| Deferred Revenue | 313.29M | ||
| Goodwill and Intangible Assets | 241.47M | ||
| Inventory | 8.39M | ||
| Liabilities Non-Current | 92.01M | ||
| Trade and Non-Trade Payables | 95.12M | ||
| Tax Assets | 11.67M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 8.91M | ||
| Net Cash Flow from Financing | 3.61M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 7.45M | ||
| Capital Expenditure | -3.07M | ||
| Issuance (Purchase) of Equity Shares | 3.61M | ||
| Net Cash Flow from Investing | -13.75M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -2.12M | ||
| Net Cash Flow from Operations | 17.59M | ||
| Effect of Exchange Rate Changes on Cash | 110.00K | ||
| Share Based Compensation | 15.25M | ||